Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

Journal of Pathology

Volumn 185, Issue 3, 1998, Pages 236-245

  Srinivasan, Radhika ^a   Poulsom, Richard ^b   Hurst, Helen C ^a   Gullick, William J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

C erbB 4; Growth factor receptor; HER4; Human cancer; Tyrosine kinase

Indexed keywords

GROWTH FACTOR RECEPTOR; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ADENOCARCINOMA; ADULT; ANIMAL CELL; ARTICLE; ASTROCYTOMA; BRAIN DEVELOPMENT; BREAST; CARDIOVASCULAR SYSTEM; ENDOCRINE SYSTEM; FETUS; GASTROINTESTINAL TRACT; HEART DEVELOPMENT; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUSCULOSKELETAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; SKIN; SOLID TUMOR; TISSUE DISTRIBUTION; UROGENITAL SYSTEM;

ADENOCARCINOMA; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; BREAST; CARCINOMA, SQUAMOUS CELL; CARDIOVASCULAR SYSTEM; DIGESTIVE SYSTEM; ENDOCRINE SYSTEM; EPITHELIUM; FETUS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MUSCULOSKELETAL SYSTEM; NEOPLASMS; NERVOUS SYSTEM; RABBITS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY SYSTEM; RNA, MESSENGER; SKIN; UROGENITAL SYSTEM;

EID: 0031827634     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7     Document Type: Article

References (32)

1. erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 1993; 90: 1746-1750.
2. Zimonjie DB, Maurizio A, Miki T, Popescu NC, Kraus MH. Localization of the human HER4/erbB-4 gene to chromosome 2. Oncogene 1995; 10: 1235-1237.
3. Prigent SA, Lemoine NR, The type I (EGFR related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992; 4: 1-24.
4. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991; 47: 87-98.
5. Rajkumar T, Goden CSR, Lemoine NR. Gullick WJ. Expression of the c-erbB-3 protein in gastrointestinal tumours determined by monoclonal antibody RTJ1. J Pathol 1993; 170: 271-278.
6. Quinn CM, Ostrowski JL, Lane SA, Loney DP, Teasdale J, Benson FA. c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathohgy 1994; 25: 247-252.
7. Rajkumar T, Gullick WJ. The type-I growth factor receptors in human breast cancer. Breast Cancer Res Treat 1994; 29: 3-9.
8. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene. Science 1987; 235: 177-182.
9. Rajkumar T, Stamp GWH, Pandha HS, Waxman J, Gullick WJ. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer. J Pathol 1996; 179: 381-385.
10. Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: a new signalling paradigm with implications for breast cancer research. Breast Cancer Res Treat 1995; 35: 115-132.
11. Tzahar E, Waterman H, Chen X, et al.. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 1996; 16: 5276-5287.
12. erbB4. Nature 1993; 366: 473-475.
13. Tzahar E, Levkowitz G, Karunagaran D, et al.. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all neu 3 differentiation factor/heregulin isoforms. J Biol Chem 1994; 269: 25 226-25 233.
14. Riese DJ II, Bermingham Y, van Raaij TM. Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 1996; 12: 345-353.
15. Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 1997; 16: 1268-1278.
16. Cohen BD, Green JM, Foy L, Fell HP. HER4-mediated biological and biochemical properties in NIH3T3 cells. J Biol Chem 1996; 271: 4813-4818.
17. Sepp-Lorenzino L, Eberhad I, Ma Z, et al.. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells. Oncogene 1996; 12: 1679-1687.
18. Zhu X, Lai C, Thomas S, Burden SJ. Neuregulin receptors, erbB3 and erbB4 are localized at neuromuscular synapses. EMBO J 1995; 14: 5842-5848.
19. Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res 1996; 56: 1184-1188.
20. Lyne JC, Melhem MF, Finley GG, et al.. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro. Cancer J Sci Am 1997; 3: 21-30.
21. Gilbertson RJ, Perry RH, Kelly PJ, Pearson ADJ, Lunee J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoa. Cancer Res 1997; 57: 3272-3280.
22. Rajkumar T, Gullick WJ. The production of antibodies using synthetic peptides as immunogens. In: Jankowski JA, Polak JM, eds. Clinical Gene Analysis and Manipulation. Cambridge: Cambridge University Press, 1996; 99-110
23. Waterfield MD, Mayes ELV, Stroobant P, et al.. A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochcm 1982; 20: 149-161.
24. Gullick WJ, Downward J, Foulkes JG, Waterfield MD. Antibodies to the ATP-binding site of the human epidermal growth factor (EGF) receptor as specific inhibitors of EGF-stimulated protein-kinase activity. Eur J Biochem 1986; 158: 45-253.
25. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ. Expression of the c-erbB-3 protein in normal human adult and foetal tissues, Oncogene 1992; 7: 1273-1278.
26. Senior PV, Critchley DR, Beck F, Walker RA, Varley JM. The localization of laminin mRNA and protein in the post-implantation embryo and placenta of the mouse: in situ hybridization and immunocytochemical study. Development 1988; 104: 431-446.
27. Zandvliet DW, Hanby AM, Austin CA, et al.. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridization. Biochim Biaphys Actaa 1996; 1307: 239-247.
28. Damjanov I, Mildner B, Knowles BB. lmmunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 1986; 55: 588-592.
29. Gusterson B, Cowley G, Smith JA, Ozannc B. Cellular localization of human epidermal growth factor receptor. Cell Biol Int Rep 1984; 8: 649-658.
30. Press MF, Cordon-Cardo C, Slamon DJ. Expression of the HER-2/neu proto-oncogene in normal human adult and foetal tissues. Oncogene 1990; 5: 953-962.
31. Li W, Park JW, Nuijens A, Sliwkowski MX, Keller GA, Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene 1996; 12: 2473-2477.
32. Gassmann M, Casagranda F, Orioli D, et al.. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995; 378: 390-394.